InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Lai Goldman Myla, Director. Director active across 4 companies, notably West Pharmaceutical Services INC. Aggregated, 12 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €93k. Activity tracked since 12 June 2023. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lai Goldman Myla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
8,073 sharesCommon StockSEC:0001168581-26-000002:0
23,372 shares0Common StockSEC:0001168581-26-000001:0
2,084 shares@ US$5.54100.0% of flowCommon StockSEC:0001168581-25-000003:0
20,000 sharesCommon StockSEC:0001062993-25-012722:0
2,940 sharesCommon StockSEC:0001562180-25-005380:0
1,071 shares0Common StockSEC:0001127602-25-013709:0
564 shares0Common StockSEC:0001127602-24-013406:0
20,000 shares@ US$5.00100.0% of flowCommon StockSEC:0001104659-23-070484:0
Canonical exit: 10 Sept 2023 (T+90)
616 sharesCommon StockSEC:0001562180-23-003696:0
632 sharesCommon StockSEC:0001562180-22-004429:0
577 sharesCommon StockSEC:0001562180-21-003309:0
31,085 sharesCommon StockSEC:0001193614-16-000050:0
12 of 12 declarations
About Lai Goldman Myla
LAI GOLDMAN MYLA is a Director at West Pharmaceutical Services INC, Akoya Biosciences, Inc. and SEQUENOM INC. She has 8 filings in total, and across the 8 sampled filings the reported activity is mainly an attribution, with 92911 EUR of buys and 0 EUR of sells, between 2016-01-06 and 2025-05-08. The largest listed filing is for Akoya Biosciences, Inc. on 2023-06-12 for 92910.99919821888 EUR.
